Obi Agbim

GuardG
Good to go Saturday
GBaylor
January 3, 2026
Agbim (illness) is available for Saturday's game against TCU, Jon Rothstein of CBS Sports reports.
ANALYSIS
Agbim missed Baylor's most recent contest due to illness, but he's feeling well enough to suit up Saturday. The senior guard is averaging 11.7 points, 3.7 assists, 2.5 rebounds and 1.0 steals across 32.4 minutes per game this season. He boasts 43/43/89 shooting splits.
Read More News
College Basketball Stats
Loading CBB Stats...
2024 CBB Game Log
2025
2024
2025 CBB Game Log
Calculate Stats Over Time
Just click on any two dates.
Scoring
FanDuel
DraftKings
Head2Head
Loading Game Log...
2024 CBB Game Log
Calculate Stats Over Time
Just click on any two dates.
Scoring
FanDuel
DraftKings
Head2Head
Loading Game Log...
2025 CBB Split Stats
Loading CBB Stats...
Bears Depth Chart
Our full team depth charts are reserved for RotoWire subscribers.
Subscribe Now
Recent RotoWire Articles Featuring Obi Agbim See More
Recent RotoWire Articles Featuring Obi Agbim See More
More Fantasy News
Probable to play Saturday
GBaylor
Illness
January 2, 2026
Agbim (illness) is probable for Saturday's game against TCU.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Won't play Saturday
GBaylor
Illness
December 29, 2025
Agbim has been ruled out for Saturday's game against TCU due to illness.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Shows off full arsenal
GBaylor
December 10, 2025
Agbim contributed 18 points (6-11 FG, 4-9 3Pt, 2-2 FT), four rebounds, five assists and three steals across 32 minutes during Wednesday's 97-67 win over Norfolk State.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Commits to Baylor
GBaylor
March 31, 2025
Agbim has committed to Baylor for the 2025-26 season, Joe Tipton of On3.com reports.
ANALYSIS
Subscribe now to instantly reveal our take on this news.
Entering portal
GFree Agent
Transfer Portal
March 17, 2025
Agbim is entering the NCAA's transfer portal, according to Joe Tipton of On3.
ANALYSIS
Subscribe now to instantly reveal our take on this news.